An Interview with Dr. Peter Marks
Cell & Gene: The Podcast
00:00
Evolution of Cell and Gene Therapies at the FDA
The chapter explores the growth and transition within the field of Cell and Gene Therapies during Dr. Marks's tenure at the FDA, emphasizing the increase in approved therapies. It discusses the need for improvements within CBER, the impact of the pandemic on staffing, and the reorganization efforts to regulate cell and gene therapies effectively.
Transcript
Play full episode
